[Intraperitoneal administration of fibrinolysin, hydrocortisone and novocaine for the prevention of recurrences of adhesive obstruction of the intestines].
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005341:Fibrinolysin / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage*; D007274:Injections, Intraperitoneal; D007415:Intestinal Obstruction / Q000517:prevention & control*; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011343:Procaine / Q000008:administration & dosage*; D012008:Recurrence; D000267:Tissue Adhesions
D011343:Procaine; D005341:Fibrinolysin; D006854:Hydrocortisone
Vnutribriushinnoe vvedenie fibrinolizina, gidrokortizona i novokaina dlia preduprezhdeniia retsidivov spaechnoĭ neprokhodimosti kishechnika.